Answers are grounded in this paper and cite their sources.
Introduction: Even though the cornea is one of the most widely transplanted solid tissues, it is estimated that approximately 98% of patients requiring a transplant lack access to this sight-saving procedure. This critical gap is a direct consequence of a tremendous global donor shortage, highlighting the urgent need for bioengineered alternatives. Despite significant research efforts, creating a functional bioengineered cornea remains a major challenge. The present study investigates a novel biomimetic approach leveraging Plasma Rich in Growth Factors (PRGF) technology in combination with dental pulp stem cells. Material and methods: Human dental pulp stem cells (hDPSCs) were isolated, characterized, and differentiated into epithelial, stromal, and endothelial corneal phenotypes. Two distinct types of corneal grafts were developed, categorized by the differentiation stage of the incorporated hDPSCs. The bioengineered constructs consisted of a central bioactive PRGF-fibrin core embedding cells and sandwiched between a trilaminar anterior layer and a posterior cell sheet. The PRGF-derived supernatant was utilized as a medium supplement. The resulting corneal substitutes were evaluated for their optical and rheological properties, as well as cellular viability. Finally, the structural stability and remodeling kinetics of the bioengineered grafts were histologically examined and quantified. Results: collagen synthesis. Conclusion: Bioengineered grafts comprising a central PRGF membrane fibrin core integrated with hDPSCs to mimetically replicate the trilaminar cellular architecture of the cornea, represent a dynamic biomimetic candidate for future clinical applications in corneal transplantation surgery.
No takes yet. Share an insight, caveat, or question.
Anitua et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: